Revolution Medicines, Inc.
25.67xPrice / tangible book
Market cap
$45.01B
Tangible equity
$1.75B
Price / tangible book
25.67x
Price / book
24.65x
Return on equity
-23.9%
Return on assets
-21.2%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: RVMD stock price at premium vs HBAN $210.02 current versus $15.52 implied using P/TBV multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HBAN's multiple
Implied fair value · at RVMD's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Multiple premium
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: RVMD FY 2023 (ended Dec 31, 2023) · HBAN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$45.01B
Tangible equity
$1.75B
Price / tangible book
25.67x
Price / book
24.65x
Return on equity
-23.9%
Return on assets
-21.2%
Efficiency ratio
—
Price / tangible book
Market cap
$34.52B
Tangible equity
$18.20B
Price / tangible book
1.90x
Price / book
1.42x
Return on equity
9.1%
Return on assets
1.0%
Efficiency ratio
40.2%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Revolution Medicines, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Huntington Bancshares Incorporated · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
0.76x
Net debt / EBITDA
Leverage against operating earnings
3.85x
—
Cash and equivalents
Liquid reserves on the balance sheet
$1.85B
—
Total debt
Interest-bearing obligations outstanding
$193.93M
$18.48B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
RVMD vs AMGN
BRISTOL MYERS SQUIBB CO
RVMD vs BMY
GILEAD SCIENCES, INC.
RVMD vs GILD
INCYTE CORP
RVMD vs INCY
VERTEX PHARMACEUTICALS INC / MA
RVMD vs VRTX
Moderna, Inc.
RVMD vs MRNA
JPMorgan Chase & Co.
RVMD vs JPM
Bank of America Corporation
RVMD vs BAC
Wells Fargo & Company
RVMD vs WFC
Citigroup Inc.
RVMD vs C
PNC FINANCIAL SERVICES GROUP, INC.
RVMD vs PNC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.